Followers | 9839 |
Posts | 260002 |
Boards Moderated | 4 |
Alias Born | 12/27/2006 |
Friday, January 10, 2020 3:58:13 PM
Link to Video - click here to watch the technical chart video
Recent ACRS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:08:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:04:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:02:09 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 12:30:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 12:14:59 PM
- Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update • GlobeNewswire Inc. • 02/27/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 01:32:20 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:06:10 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:24:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:36:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:31:24 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:29:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:27:54 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/05/2024 09:31:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:30:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 12:30:10 PM
- Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review • GlobeNewswire Inc. • 01/16/2024 12:00:00 PM
- Aclaris Therapeutics Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis • GlobeNewswire Inc. • 01/10/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:47:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:44:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:15:25 PM
- Aclaris Therapeutics Provides Corporate Update • GlobeNewswire Inc. • 12/19/2023 09:01:00 PM
- Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia • GlobeNewswire Inc. • 12/05/2023 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 12:42:20 PM
- Aclaris Therapeutics Announces Top-line Results from 12-Week Phase 2b Trial of Oral Zunsemetinib (ATI-450) for Moderate to Severe Rheumatoid Arthritis and Provides Corporate Update • GlobeNewswire Inc. • 11/13/2023 12:00:00 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM